Statin use and pancreatic cancer: a risk assessment. Authors? reply

Affiliations

¹ Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
² Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: capurso.gabriele@hsr.it.

Comment

Livia Archibugi et al. Dig Liver Dis. 2019 May.

. 2019 May;51(5):750-751.

doi: 10.1016/j.dld.2019.02.021. Epub 2019 Mar 27.

¹ Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
² Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: capurso.gabriele@hsr.it.

No abstract available

Comment on

Statin use is associated to a reduced risk of pancreatic cancer: A meta-analysis.
Archibugi L, Arcidiacono PG, Capurso G. Archibugi L, et al. Dig Liver Dis. 2019 Jan;51(1):28-37. doi: 10.1016/j.dld.2018.09.007. Epub 2018 Sep 20. Dig Liver Dis. 2019. PMID: 30314951
Statin use and pancreatic cancer: A risk assessment.
Kawada T. Kawada T. Dig Liver Dis. 2019 May;51(5):749. doi: 10.1016/j.dld.2019.02.011. Epub 2019 Feb 28. Dig Liver Dis. 2019. PMID: 30926286 No abstract available.